phd pharmacy finland

Doctoral Programme in Drug Research

The following major subjects are included in the Doctoral Programme in Drug Research:

• Drug Development

Special criteria for admission to the Doctoral Programme in Drug Research

The research plan should be written according to the instructions in the individual study plan (ISP). You will find the ISP and further information at Apply for Doctoral Studies .

Study plan for the Doctoral Programme in Drug Research

The Doctoral degree (240 credits) includes:

• Research studies (40 credits)
• Doctoral dissertation (thesis) (200 credits)

If you choose to complete your Licentiate degree (120 credits), this includes:

• Licentiate thesis (80 credits)

A Doctoral degree taken after a Licentiate degree only includes a Doctoral dissertation (thesis) (120 credits).

In the individual study plan (ISP), you must state the year in which you plan to complete your degree. The average length of time needed is 60 credits per academic year in full-time studies, amounting to 4 years in total. If you deviate from this schedule, you must provide an explanation for doing so.

Doctoral studies within the Doctoral Programme in Drug Research

The doctoral studies within the Doctoral Programme in Drug Research (40 credits) must support your thesis work. You are to plan your studies together with the supervisor. You may complete your studies at Åbo Akademi University or another university.

Studies include:

• at least 25 credits in the major subject
• max. 5 credits for participation in conferences (5 credits requires participation with your own contribution in at least 2 international conferences).
• max. 5 credits for language studies

The faculty recommends that working life skills are included as part of the doctoral studies (equivalent to 10-20 credits). Working life skills consist of, for example, teaching and supervision work, pedagogical competences, communication, scientific writing, computer skills and language proficiency, and studies in university pedagogy.

Apply for doctoral studies

Here’s how to apply for doctoral studies at Åbo Akademi University: 1) Check to see whether you are eligible to apply for doctoral studies. You

Facts on the Graduate School at Åbo Akademi University

The Graduate School at Åbo Akademi University is an umbrella unit for Åbo Akademi doctoral programmes. The purpose of the Graduate School at Åbo Akademi

Doctoral studies

Doctoral studies at Åbo Akademi University are organised in the form of doctoral programmes. A faculty may have several doctoral programmes and a single doctoral

Uppdaterad 19.6.2023

Drug Research Doctoral Programme - Admission Criteria and Instructions for Applicants

DRDP serves as a postgraduate programme for graduates of the Master’s Degree Programme in Drug Discovery and Development at the University of Turku but it is open to applicants from anywhere in the world, who have a suitable M.Sc. level education and an interest in drug research.

The training provides a general view of the drug development process, starting from molecular and mechanistic levels and continuing to preclinical and clinical drug research, pharmaceutical development, and pharmacoepidemiology.

The doctoral researchers of Drug Research Doctoral Programme (DRDP) carry out their doctoral studies at the Faculty of Medicine, the Faculty of Science or the Faculty of Technology.

Industrial PhD (iPhD) training in DRDP

DRDP has an industrial doctorate track (iPhD) in collaboration with industrial partners. The aim of the industrial doctorate training is to educate doctors to strong scientific thinking in combination with applied research expertise, and capabilities to work in both academic and industrial research environments as well as in their interface. Doctoral researchers on the iPhD track will carry out their research primarily (>75 % of total 4 years) in an industrial environment, and are supervised by both industrial and academic supervisors. The academic training is composed of academic secondments (akateeminen työskentelyjakso, max 25 %), and post-graduate education courses at the UTU.

Doctoral researchers with immunology, immunology-based drug development and/or diagnostics as their field of study have the possibility of applying for  the InFLAMES Doctoral Module and of including the studies offered within the module as part of their doctoral studies.

> Application periods for doctoral training

The next application period is 1.5.-15.5.2024 (ends at 3:00 p.m.). The right to study for a doctoral degree will start on 1 August 2024.

Call II for applications DRDP Spring 2024 (pdf)

Previous call (28.2-28.3.2024) DRDP call for UTUGS applications (pdf)

Upcoming call (1.5.-15.5.2024): Call II for applications DRDP Spring 2024 (pdf) 

Instructions for the applicants

> Faculty of Medicine

> Faculty of Science

>Faculty of Technology

Please read carefully the guidelines for applying

> Faculty of Science 

Prepare also the documents mentioned in the call for applications of the Drug Research Doctoral Programme.

•     Check the application period
•     Read the instructions of the faculty in question and the doctoral programme carefully!
•     If you are going to verify your language skills with a language test, make sure that you book your test time well in advance. It is the applicant’s responsibility to make his/her own language test arrangements
•     Get the required signatures in time and prepare the appendices
•     Fill in the electric application form
•     Remember to apply in time
•     Keep your original certificates at hand and prepare to acquire officially certified copies if needed!

A link to the electronic application form, the list of required attachments and a guide for filling in the form will be available during the application period.

Application period and what can be applied for

On the period of 1.5.-15.5.2024 applications are invited for the right to study at the University of Turku in the Faculty of Medicine or Faculty of Science or Faculty of Technology in Drug Research Doctoral Programme. The right to study for a doctoral degree will start on 1 August 2024.

Eligible applicants with a research topic fitting the scope of DRDP can apply. The motivation to apply to DRDP is presented in the motivation letter. Each applicant should have two supervisors* with at least one supervisor affiliated with University of Turku and holding an UTU -account to use the UGIS system. 

To plan the theoretical studies, applicants should take into account the Learning outcomes of DRDP, their research project and individual career plans.

DRDP doctoral researchers in the Faculty of Science or Technology of are required to include at least 5 credits of doctoral programme specific training by DRDP in their postgraduate studies. Same is recommended to the DRDP doctoral researchers in the Faculty of Medicine. It is strongly recommended that every doctoral researcher actively participates in the annual meetings of the DRDP and the annual meetings of FinPharmaNet and gives an oral presentation at least once during their doctoral studies at one of the events.

Follow-up committee is an important part of the PhD studies in DRDP. The role and tasks of the follow-up committee are listed in detail in the study guide . DRDP follow-up committee comprises of supervisors and 1-3 other researchers familiar with the research topic, one of whom must be from outside the doctoral researcher's own group. At least one of the external members should be affiliated with University of Turku and be familiar with the practicalities of doctoral training in the Faculty and in DRDP. The follow-up committee ensures progress of the doctoral researcher's thesis work and studies, provides an external perspective on the research, and supports both researcher and supervisor(s). The applicant negotiates with their supervisor(s) to assemble the follow-up committee and agrees with the members of the committee on annual monitoring practices.

* At Faculty of Medicine: When only one supervisor for doctoral training is proposed, the supervisor’s justified plea for approval of only one supervisor must be attached to the application. 

The applicants will be invited to interview after preliminary selection. The interview will contain a brief presentation by the Applicant and an interview by the Board of the DRDP. The invitation with detailed instructions will be sent by email.

Application and document preparation:

>> apply here.

1) Fill in the electronic application form found in Opintopolku / StudyInfo (link will be open from 1.5.2024 00:00 to 15.5.2024 (3:00 p.m.). 2) attach PDF file documents into the application according to Faculty of Medicine or Faculty of Science/Technology requirements.

Instructions for DRDP applicant_2024 to fill in the application form

See below the separate instructions for applying to the Faculty of Medicine or Faculty of Science/Technology. The application documents will not be returned to the sender.

The electronic application form should include the following attachments:

At the Faculty of Medicine

1. Motivation letter (why do you wish to perform doctoral studies in this doctoral programme)

2. CV of the applicant, including a list of publications when applicable (it is mandatory to use attached CV model )

3. Structured research plan approved by the supervisor (max 5 pages).

The plan should consist of: abstract, background, aims and hypotheses, significance, how will the plan be carried out in practice, research environment, timetable and funding plan.

By attaching the research plan to the application form the applicant gives permission for checking the research plan with Turnitin Originality Check (system for electrical plagiarism detection).

The research plan should follow the guidelines for the responsible conduct of research (see Responsible Conduct of Research (RCR) | Finnish National Board on Research Integrity TENK ). The research plans can be checked with the Turnitin OriginalityCheck plagiarism detection software. The use of artificial intelligence (AI) to assist in the preparation of the research plan should be clearly indicated in the research plan.

4. Supervision and study plan - the Faculty of Medicine form: Supervision and study plan - fill in electronically, print, sign together with the supervisor/-s and the head of subject and scan as an attachment (a mandatory attachment in the Faculty of Medicine)

See: Subjects in doctoral training and heads of doctoral subject

Note! Industrial PhD Track (iPhD) applicants of the Medical Faculty attach filled iPhD supervision and study plan to the application as an attachment as instructed in the application form!

5. A university degree certificate , if applicant has attained the higher university degree somewhere else than in the University of Turku and in addition, a transcript of studies if the degree has been completed outside Finland.

If needed - please see the instructions: Degree giving the eligibility

Those applicants who have been granted the right to study and who have completed their studies at a University abroad have to submit officially certified copies of the degree certificates, other educational documents and the official translations of the documents to the University of Turku according to the instructions given in the admission notification. If the admitted applicant does not submit the degree documents in time as indicated in the admission notification, they shall forfeit the study place.

6. Verification of language proficiency

The University of Turku follows the Rector’s decision (15 Aug 2019) on the means of verifying one’s language proficiency. See the language requirements on the web page of the university’s graduate school.

If applicant has to pass a language test, the copy of the language test result must be attached to the application

• If needed - please see the instructions: Language proficiency

7. Copy of a valid passport

Attach a copy of your valid passport or official identification card with photo and information on citizenship. If you have a Finnish personal identity code and you have entered it on the application form, you do not need to attach a copy of your passport.

8. The supervisor’s justified plea for approval of only one supervisor when only one supervisor for doctoral training is proposed. See Before applying / Doctoral training at the Faculty of Medicine under section Supervision.

If applying for the right to study for a doctoral degree at the Faculty of Science or the Faculty of Science , the required attachments may vary from the above-mentioned. Please check and follow the instructions of the faculty in question.

At the Faculty of Science and the Faculty of Technology

The application should include the following:

2. CV of the applicant , including a list of publications when applicable (it is mandatory to use attached CV model )

By attaching the research plan to the application form the applicant gives permission for checking the research plan with Turnitin OriginalityCheck (system for electrical plagiarism detection) in accordance with the University of Turku quality assurance system.

The research plan should follow the guidelines for the responsible conduct of research (see Responsible Conduct of Research (RCR) | Finnish National Board on Research Integrity TENK ). 

The use of artificial intelligence (AI) to assist in the preparation of the research plan should be clearly indicated in the research plan.

4. Supervision plan

Use this Supervision plan at Faculty of Science and

this Supervision plan at Faculty of Technology

At the Faculty of Science or the Faculty of Technology the applicants to the iPhD track add to Supervision plan to the place for " Other things agreed" that they apply to iPhD track.

5. Degree certificates and transcripts of study records

A. If the applicant has completed the former degree(s), which make them eligible for doctoral studies at a university in Finland , the degree certificates, the transcripts of study records and other educational documents, which may be of relevance in the student selection must be attached to the electronic application form.

B. If the applicant has completed the former degree(s), which make him/her eligible for doctoral studies at a university abroad (i.e. outside Finland) , they must attach the following items to the electronic application form: • scanned original degree certificates (in the same language as the degree was completed in) • scanned original transcripts of study records (in the same language as the degree was completed in) • scanned other original educational documents which may be of relevance in the student selection • If the original degree certificates and other educational documents are not written in English, Finnish or Swedish, official translations to one of these languages must also be submitted. An official translation here refers to a translation of the educational documents issued by the awarding institution or a translation made by an authorized translator. A transcript in English can be replaced by a Diploma Supplement awarded by a European educational institution if it contains the information about completed courses and other study attainments.

6.   Verification of language proficiency

The University of Turku follows the Rector’s decision (15 Aug 2019) on the means of verifying one’s language proficiency. See the language requirements on the webpage of the university’s graduate school.

• If the applicant is required to prove their language proficiency with a language test, a scanned certificate of a completed language test must be attached to the application

Assessment of applications

The Steering Committee of the doctoral programme will assess the applications with the help of outside experts, when needed. The applicant’s motivation, merits, previous studies, and the ability to complete a doctoral degree, as well as the quality and feasibility of the research plan (drug research) and supervisor and financial arrangements are taken into consideration when selecting doctoral researchers. Selection process is stepwise and applicants will be invited to interview after preliminary selection. The invitation will be sent by email. Interview will be evaluated together with the preliminary assessment of the application for final decision. Research proposals may be checked before the selection with the Turnitin OriginalityCheck plagiarism detection software in accordance with the University of Turku quality assurance system. 

Assessment criteria

•     Research plan: Innovativeness and implementation (1-5) •     CV and motivation letter: Progress of research training, content of formal postgraduate training (in the area of the research and growth as a drug research professional), merits (awards and own funding), completion plan of the dissertation, future career plans (1-5) •     Supervision arrangements: Competence of supervisors in the field of the research, merits and activity as doctoral supervisor (including active participation in DRDP activities and organizing postgraduate courses) (1-3) •     Field of research: Relevant research topic to the DRDP (both preclinical and clinical drug research and development or supporting diagnostics), supporting research environment for the implementation of the research plan and for the development of the drug research professional (1-3)                 •     Interview: Logical and realistic presentation of research and completion plan, language and presentation skills, expertise and proficiency in discussion, motivation and commitment (1-5)

The Dean of the Faculty of Medicine or Faculty of Science or Faculty of Technology decides on granting the right to study for a doctoral degree (1 August 2024 onwards) based on the proposals of the steering committee of the Doctoral Programme. All applicants will be personally informed about the decisions by 12 June 2024 at the latest. An admitted applicant has to notify the University of Turku of their acceptance of the study place by 3:00 pm (local time in Finland) on 19 June 2024 according to the instructions given in the admission notification. If the admitted applicant does not give the notification by the end of the allotted period of time mentioned above, they forfeit the study place. A person admitted to more than one university or polytechnic degree programme only notifies the one educational institution at which they accept the study place. Notification, i.e. accepting a study place, is binding and may not be cancelled or changed later.

According to Finnish university legislation, a student may accept only one study place leading to a higher education degree in Finland during one academic term (autumn term 1 Aug – 31 Dec or spring term 1 Jan – 31 Jul). This rule applies to all higher education, i.e. Bachelor and Master level degrees awarded by Finnish universities of applied sciences, Bachelor and Master degrees awarded by Finnish universities, and Licentiate and Doctoral degrees awarded by Finnish universities. This regulation is not applied to study rights received in transfer student selections, from the Åland University of Applied Sciences, from the Police University College, and from institutions of higher education outside Finland. The applicants who have completed their prior degree in a country other than Finland and who are granted a study right in this call, need to deliver either the original degree certificates or certified copies of the original degree certificates and their translations to the University of Turku, as instructed in the admission notification, on 6 September 2024 at the latest. If the admitted applicant does not deliver the required certificates by the deadline, they forfeit the study right. Instructions on delivering certificates and country-specific requirements.

Appeal for rectification

If an applicant is dissatisfied with the result of the student selection (right to study for a doctoral degree), they have the right to submit an application for the rectification of the decision to the Faculty of Medicine or the Faculty of Science or Faculty of Technology within 14 days of the official publishing of the results.

Additional information

Faculty of Medicine: Chief Academic Officer Outi Irjala    

Faculty of Science and Faculty of Technology: Chief Academic Officer Sanna Ranto    

Additional DRDP information DRDP director professor Ullamari Pesonen, ullamari.pesonen(at)utu.fi (iPhD) Coordinator PhD Verna Louhivuori, drdp(at)utu.fi

DRDP UTUGS 2024-2025 and InFLAMES 2024: Fixed term doctoral researcher positions 2024-2025

Faculty of Pharmacy

• University of Helsinki
• Email [email protected]
• Website http://www.helsinki.fi/pharmacy/

Viikinkaari 5

Organisation profile

Fields of science.

• 317 Pharmacy

International and National Collaboration

Dive into details.

Select a country/territory to view shared publications and projects

Marja Airaksinen

• Division of Pharmacology and Pharmacotherapy - Professor
• Helsinki One Health (HOH)
• Drug Research Program

Clin­ical Phar­macy Group

• Doctoral Programme in Drug Research - Supervisor for doctoral programme
• Doctoral Programme in Population Health - Supervisor for doctoral programme

Person: UH , Teaching and research personnel, U4 Research and teaching staff

Mikko Airavaara

• Helsinki Institute of Sustainability Science (HELSUS)
• Doctoral Programme Brain & Mind - Supervisor for doctoral programme

Person: Teaching and research personnel, U4 Research and teaching staff

Teemu Aitta-aho

• Divisions of Faculty of Pharmacy - Title of Docent
• Department of Pharmacology - University Lecturer

Person: U3 Research and teaching staff

Okko Alitalo

• Doctoral Programme in Drug Research
• Divisions of Faculty of Pharmacy - Visiting scholar
• Laboratory of Neurotherapeutics

Person: Visiting scholar, Doctoral Researcher, UH

Iina Annala

• Division of Pharmacology and Pharmacotherapy - Doctoral Researcher

Person: U1 Research and teaching staff, Doctoral Researcher

Research units

Anti-infectives research.

Division of Pharmaceutical Biosciences

Organisational unit : Research group

Bioactivity Screening

Bioactivity Screening Group

Biopharmaceutics group.

Division of Pharmacology and Pharmacotherapy

Bioactivity screening unit

Päivi Tammela (Manager)

Facility/equipment : Core Facility

Drug discovery and chemical biology platform

Marjo Yliperttula (Manager)

Facility/equipment : Equipment

Extracellular Vesicle - EV Core

Pia Siljander (Manager) & Maija Puhka (Manager)

FIMM High Throughput Biomedicine Unit

In vivo small animal spect/ct imaging laboratory.

J. Arturo Garcia Horsman (Manager)

• 12 Not started
• 292 Finished

Projects per year

Suomen Parkinson-säätiö Airavaara 24-27

Airavaara, M.

Suomen Parkinson-säätiö sr

06/05/2024 → 30/04/2027

Project : Foundations (Private Foundations, Non-Profit Foundations, Charitable Trusts)

Juselius 24-27 Voutilainen

Voutilainen, M. & Adhi Sivakumar, R.

Sigrid Juseliuksen Säätiö

01/05/2024 → 30/04/2025

Liv och Hälsa 24-25 Kidron

Medicinska understödsföreningen Liv och Hälsa RF

01/05/2024 → 31/12/2025

Juselius 24-27 Airavaara

Juselius 24-27 cerullo.

Cerullo, V.

Publications

• 4077 Article
• 353 Review Article
• 241 Doctoral Thesis
• 225 Chapter
• 212 Conference contribution
• 104 Conference article
• 60 Meeting Abstract
• 28 Abstract
• 23 Master's thesis
• 22 Commissioned report
• 22 Editorial
• 15 Digital or Visual Products
• 14 Anthology or special issue
• 10 Comment/debate
• 8 Other contribution
• 7 Working paper
• 4 Other articles
• 2 Foreword / postscript
• 2 Exhibition
• 2 Performance
• 1 Other conference material
• 1 Bachelor's thesis
• 1 Licenciate's thesis

Research output per year

5-Aminothiazoles Reveal a New Ligand-Binding Site on Prolyl Oligopeptidase Which is Important for Modulation of Its Protein-Protein Interaction-Derived Functions

Research output : Contribution to journal › Article › Scientific › peer-review

A beginner's guide to study extracellular vesicles in human blood plasma and serum

Aerobic adaptation and metabolic dynamics of propionibacterium freudenreichii dsm 20271: insights from comparative transcriptomics and surfaceome analysis.

Research output : Contribution to journal › Article › Scientific

Affinity chromatography reveals direct binding of the GATA4-NKX2-5 interaction inhibitor (3i-1000) with GATA4

Albumin and cardioprotection in on-pump cardiac surgery—a post hoc analysis of a randomized trial.

• 2368 Organisation and participation in conferences, workshops, courses, seminars
• 1071 Peer review of manuscripts
• 658 Supervision of other thesis (Master's, Licentiate)
• 585 Supervisor or co-supervisor of doctoral thesis
• 447 Membership or other role in national/international committee, council, board
• 374 Public Talks
• 289 Academic visit to other institution
• 286 Academic visit at UH
• 214 Oral presentation
• 177 Pre-examiner of doctoral thesis
• 169 Types for other activities - External teaching and subject coordination
• 140 Membership or other role in public Finnish or international organization
• 133 Membership or other role in review committee
• 116 Member of doctoral thesis committee / follow-up group
• 106 Opponent of doctoral dissertation
• 104 Invited talk
• 101 Types for other activities - Other
• 72 Assessment of candidates for academic posts
• 61 Membership or other role in research network
• 49 Post doctoral mentor
• 43 Editor of research journal
• 34 Membership or other role of body in private company/organisation
• 32 Prizes and awards - Prizes and awards
• 19 Editor of special theme number
• 18 Other tasks of an expert in private sector
• 7 Editor of series
• 5 Consultancy
• 5 Non-academic visit at UH
• 4 Non-academic visit to other institution
• 3 Editor of research anthology/collection/conference proceedings
• 3 Assistant director of or other significant role in doctoral programme
• 3 Director of doctoral programme

Activities per year

Aging in Place: Improving Medication Safety and Outcomes for Elderly Finns

Niina Mononen (Attendee)

Activity : Participating in or organising an event types › Organisation and participation in conferences, workshops, courses, seminars

Finska Kemistsamfundets Årsmöte

Niklas Johansson (Invited speaker)

Activity : Talk or presentation types › Oral presentation

ISEV Blood EV workshop and educational day

Pia Siljander (Scientific Committee Member)

Viivakoodien käyttöä edistävät ja estävät tekijät lääkkeiden valmistelussa ja antamisessa lastensairaalassa – ryhmäkeskustelututkimus osastofarmaseuteille

Kirsi Kvarnström (Supervisor), Sini Karoliina Kuitunen (Supervisor), Carita Linden-Lahti (Supervisor) & Katja Janhunen (Supervisor)

Activity : Examination types › Supervision of other thesis (Master's, Licentiate)

Saron Wosenu

Michael Jeltsch (Host)

Activity : Hosting a visitor types › Academic visit at UH

2008 Outstanding Graduate Student Research Award in Pharmaceutical Technologies

Mirza, Sabiruddin (Recipient), 16 Nov 2008

Prize : Prizes and awards

2013 Highly Commended Paper Award: Factors relating to effectiveness data use in healthcare management

Blom, Marja (Recipient), 2013

2014 Control Release Society Outstanding Oral Drug Delivery Paper Award

Zhang, Hongbo (Recipient), 16 Jul 2014

2016 ACADEMY OF FINLAND AWARD FOR SOCIAL IMPACT

Santos, Hélder A. (Recipient), 24 Nov 2016

2019 OrD Trainee Video Competition

Martins, João Pedro (Recipient), 1 Mar 2019

IDAAPM: integrated database of ADMET and adverse effects of predictive modeling based on FDA approved drug data

Ghemtio, L. (Creator), Journal of cheminformatics, 2017

DOI : 10.1186/s13321-016-0141-7 , http://idaapm.helsinki.fi

Artificial cell membranes on microchips for affinity chromatography

Boije af Gennäs, G. (Creator), Academy of Finland, 1 Oct 2016

ProteomeXchange / PRIDE dataset ID PXD030232

Hanski, L. (Creator), Taavitsainen-Wahlroos, E. (Creator), Miettinen, I. (Creator), Reigada, I. (Creator), Savijoki, K. (Creator) & Nyman, T. A. (Creator), European Bioinformatics Institute, 14 Apr 2022

Press/Media

Suo­ma­lais­tut­ki­jat ha­lua­vat py­säyt­tää de­men­tian, hii­ril­lä muis­ti­ko­kei­den tu­lok­set olivat jo yl­lät­tä­vän hyviä – yksi ongelma jar­rut­taa lääk­keek­si ete­ne­mis­tä.

Timo Myöhänen

1 Media contribution

Press/Media : Press / Media

Suomalaistutkijat haluavat pysäyttää dementian, hiirillä muistikokeiden tulokset olivat jo yllättävän hyviä – Yksi ongelma jarruttaa lääkkeeksi etenemistä

Mullistava tutkimus muisti­sairauden hoidosta – haitallisen aineen kertymistä aivoihin onnistuttiin estämään.

1 item of Media coverage

Tutkimus: Muistisairauksien estämiseen löytyi mahdollinen ratkaisu

Apteekkitoiminnan uudistus on tehtävä huolellisesti.

Juho Wedenoja , Leena Reinikainen & Leena Katariina Saastamoinen

Doctoral funding

On doctoral level, no tuition fees are charged, but you will need to cover your living expenses. When you apply for doctoral admission , you can ask the Finnish university department for advice on research funding options. The university departments may have paid doctoral research positions available, or doctoral funding schemes of their own. They can usually also best direct you to potential grant-awarding foundations in your field of scientific research.

EDUFI Fellowships

The national EDUFI Fellowship scholarship programme is available for doctoral level studies and research in Finland.

• EDUFI Fellowship information on the EDUFI home pages

Note that you can not independently apply for the EDUFI Fellowship - the "applicant" in this scholarship programme is your Finnish university department. So, in order to be eligible for the EDUFI Fellowship, you must first successfully apply for doctoral admission .

If you have questions regarding the EDUFI Fellowship itself, please contact the scholarships admins directly. You can find their contact details on the above EDUFI Fellowship web page.

Note that EDUFI Fellowships are not full degree scholarships but "start-up grants" awarded for a maximum of 12 months. After the EDUFI scholarship period the student/researcher will need to find other sources of funding.

Other funding resources

For more information on scientific research funding in Finland, see the Research Council of Finland website and the Research.fi funding calls database .

Paid Doctoral positions may also be available - see links to the universities' Doctoral info pages in the section Doctoral Admissions .

Finland Doctoral Fellowships

As part of the Finland Scholarship programme, Finland Fellowships is a funding option for non-EU/EEA students and researchers admitted to start their Doctoral studies at one of Finnish research and arts universities.

The Finland Fellowship contributes to the salary paid by your Finnish university and also includes a 2000€ arrival grant. Check the availability and application details of the Finland Fellowship with the Finnish university you're interested in. Finland Doctoral Fellowships are available from 2022 to 2024. The scholarships are funded by the Ministry of Education and Culture.

PhD Pharmacy programs in Finland

Drug discovery and development.

University of Turku

The Times Higher Education World University Rankings is the only global university performance table to judge research-intensive universities across all of their core missions: teaching, research, knowledge transfer and international outlook.

Deadline information

Best universities with pharmacy in finland.

Bachelor Pharmacy programs in Finland

Master Pharmacy programs in Finland

Most Popular Pharmacy programs in Finland

PhD Pharmacy programs in Finland

We use cookies to give you the best online experience. Their use improves our sites' functionality and enables our partners to advertise to you. By continuing to use our website or clicking on the I agree button you are agreeing to our use of cookies in accordance with our Cookie Policy. Details on how we use cookies can be found in our Cookie Policy

Don’t miss out!

Sign up or Log in now to save your favorites.

Get updates on your chosen subjects and programs

Wishlist your ideal programs

Save time sending enquiries to programs providers

• Program Finder
• Internships
• Scholarships
• Collections
• Bachelor programs
• Masters programs
• PhD programs
• MBA programs
• PostDoc programs
• Norway programs
• US programs
• UK programs
• Canada programs
• Germany programs
• Italy programs
• Netherlands programs
• Australia programs
• New Zealand programs
• Applied Sciences
• Natural Sciences
• Social Sciences
• Clients and Partners
• Public relations

University of Eastern Finland participates in Kuopio Pride Week

Doctoral defence of mette heiskanen, msc, 14 june 2024: blood micrornas could be useful in the diagnostics of traumatic brain injury, doctoral defence of nadine huber, msc, 14 june 2024: synaptic dysfunction correlates with frontotemporal dementia symptoms, course on multilateral environmental agreements, international workshop on orthodox theology: ad fontes – back to the roots, doctoral conferment ceremony.

Find more news and events

Refine your search

UEF Doctoral School

The University of Eastern Finland's Doctoral School and the associated doctoral programmes are responsible for arranging scientific doctoral studies at our university. Our doctoral programmes offer teaching and supervision for doctoral researchers. The aim is to ensure the high quality of doctoral education and to educate highly skilled researchers and experts.

The director of the doctoral school is Academic Rector Tapio Määttä. Administration of the school is coordinated by Head of Education Kaisa Laitinen, and the development of the doctoral school's activities and teaching programme are coordinated by Senior Lecturer Merja Lyytikäinen (contact information below).

Upcoming public examinations of doctoral dissertations

New in doctoral education

The University of Eastern Finland is involved in 11 doctoral education pilots. New doctoral positions with three-year employment contracts will be available.

Learn more about the doctoral education pilots

Doctoral programmes

Doctoral education in the University of Eastern Finland is arranged in 13 discipline specific or thematic doctoral programmes. Further information about applying to programmes, research areas and doctoral studies can be found on the homepages of doctoral programmes.

Philosophical Faculty

• Doctoral Programme in Educational Studies
• Doctoral Programme in Social and Cultural Encounters
• Welfare, Health and Management (WELMA) Doctoral Programme

Faculty of Science, Forestry and Technology

• Doctoral Programme in Science, Forestry and Technology

Faculty of Health Sciences

• Doctoral Programme in Clinical Research
• Doctoral Programme in Drug Research
• Doctoral Programme in Molecular Medicine
• Doctoral Programme in Health Sciences

Faculty of Social Sciences and Business Studies

• Past, Space and Environment in Society Doctoral Programme
• Doctoral Programme in Business Studies
• Doctoral Programme in Law

Content related to doctoral education

Instructions and forms

Find information for different phases in the doctoral education on Kamu Student handbook.

Doctoral researcher positions

Learn more about salary-paying UEF doctoral researcher positions and shared doctoral researcher positions.

For grant-based researchers

We have gathered information and instructions for grant-based researchers in Kamu Student handbook.

Conferment ceremonies

The Doctoral Conferment Ceremony shows appreciation for persons who have completed a doctoral degree.

Contact information

The UEF Doctoral School coordinates doctoral education at the university and provides transferable skills studies to all of the university's doctoral students. All doctoral students are automatically included in the doctoral school.

Doctoral programmes processes applications and makes proposals for the faculties on the rights to study to be granted. They are responsible for the organisation of subject-related doctoral studies, and for the supervision of doctoral students.

Faculties are responsible for the administration of doctoral studies. Faculties decide on requirements of doctorates, approve the doctoral studies curricula, grant the right to pursue doctoral studies, approve the research topic and research supervisor(s), research and doctoral study plans and any changes made to these. Faculties also appoint the preliminary and final examiners for doctoral dissertations and licentiate theses and the opponents and the chairman of the public examination (the Custos) for doctoral dissertations. Faculties grant the permission for the public examination, approve and grade the licentiate thesis and the doctoral dissertation, and approve completed doctoral degrees, award the degrees and give the degree certificates.

Development of the doctoral school's activities and teaching programme: Senior Lecturer Merja Lyytikäinen .

Administration of the doctoral school: Head of Education Kaisa Laitinen .

Contact information of the directors and coordinator of the doctoral programmes can be found on the homepages of programmes .

Contact person: Amanuensis Kaisu Kortelainen .

E-mail: [email protected]

Contact person: Head of Education Kaisa Laitinen .

E-mail: [email protected]

Contact persons: Head of Education Annikki Honkanen and Academic Affairs Coordinator Anne Korhonen .

• Download PDF
• Share X Facebook Email LinkedIn
• Permissions

Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation : Post Hoc Analysis of the ELAN Randomized Clinical Trial

• 1 Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
• 2 University Institute of Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
• 3 Clinical Trials Unit, University of Bern, Bern, Switzerland
• 4 Department of Neurology, University of Basel and University Hospital Basel, Basel, Switzerland
• 5 Department of Neurology, Medical University of Graz, Graz, Austria
• 6 Division of Neuroradiology, Vascular and Interventional Radiology, Department of Radiology, Medical University of Graz, Graz, Austria
• 7 Support Center for Advanced Neuroimaging, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland
• 8 Department of Neurology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland
• 9 Internal, Vascular, and Emergency Medicine, Stroke Unit, Santa Maria della Misericordia Hospital, University of Perugia, Perugia, Italy
• 10 Department of Neurology, University Medical Center Hamburg–Eppendorf, Hamburg, Germany
• 11 Department of Neurology, University Hospital Lausanne, University of Lausanne, Lausanne, Switzerland
• 12 Department of Neurology, Cantonal Hospital Aarau, Aarau, Switzerland
• 13 Department of Neurology, Oslo University Hospital, Oslo, Norway
• 14 Research Department, Reha Rheinfelden, Rheinfelden, Switzerland
• 15 Stroke Center, Lisbon Central University Hospital, Lisbon, Portugal
• 16 Faculty of Medicine, Institute of Anatomy, University of Lisbon, Lisbon, Portugal
• 17 Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India
• 18 Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
• 19 Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan
• 20 Department of Neurology, Pavol Jozef Šafárik University, Košice, Slovakia
• 21 Faculty of Medicine, Louis Pasteur University Hospital, Košice, Slovakia
• 22 Department of Neurosciences, Experimental Neurology, KU Leuven, Leuven, Belgium
• 23 Department of Neurology, University Hospitals Leuven, Leuven, Belgium
• 24 Department of Neurology, Shaare-Zedek Medical Center, Jerusalem, Israel
• 25 Stroke Clinical Trials Network Ireland, School of Medicine, University College Dublin and Department of Neurology, Mater University Hospital, Dublin, Ireland
• 26 School of Cardiovascular and Metabolic Health, Queen Elizabeth University Hospital, University of Glasgow, Glasgow, United Kingdom

Question   Does infarct size modify the safety and efficacy of early vs late initiation of direct oral anticoagulation (DOAC) after ischemic stroke in people with atrial fibrillation?

Findings   In this post hoc analysis of 1962 participants from the Early Versus Later Anticoagulation for Stroke With Atrial Fibrillation (ELAN) randomized clinical trial, the odds of the primary outcome (recurrent ischemic stroke, symptomatic intracranial hemorrhage, extracranial bleeding, systemic embolism, or vascular death within 30 days) were similar for early vs late DOAC initiation among participants with minor, moderate, and major stroke.

Meaning   Early DOAC treatment was not associated with a higher rate of bleeding complications, especially symptomatic intracranial hemorrhage, or any adverse events regardless of infarct size, including major stroke.

Importance   Whether infarct size modifies the treatment effect of early vs late direct oral anticoagulant (DOAC) initiation in people with ischemic stroke and atrial fibrillation is unknown.

Objective   To assess whether infarct size modifies the safety and efficacy of early vs late DOAC initiation.

Design, Setting, and Participants   Post hoc analysis of participants from the multinational (>100 sites in 15 countries) randomized clinical Early Versus Later Anticoagulation for Stroke With Atrial Fibrillation (ELAN) trial who had (1) acute ischemic stroke, (2) atrial fibrillation, and (3) brain imaging available before randomization. The ELAN trial was conducted between October 2017 and December 2022. Data were analyzed from October to December 2023 for this post hoc analysis.

Intervention   Early vs late DOAC initiation after ischemic stroke. Early DOAC initiation was within 48 hours for minor or moderate stroke or on days 6 to 7 for major stroke; late DOAC initiation was on days 3 to 4 for minor stroke, days 6 to 7 for moderate stroke, and days 12 to 14 for major stroke.

Main Outcomes and Measures   The primary outcome was a composite of recurrent ischemic stroke, symptomatic intracranial hemorrhage, extracranial bleeding, systemic embolism, or vascular death within 30 days. The outcome was assessed according to infarct size (minor, moderate, or major) using odds ratios and risk differences between treatment arms. Interrater reliability for infarct size between the core laboratory and local raters was assessed, and whether this modified the estimated treatment effects was also examined.

Results   A total of 1962 of the original 2013 participants (909 [46.3%] female; median [IQR] age, 77 [70-84] years) were included. The primary outcome occurred in 10 of 371 participants (2.7%) with early DOAC initiation vs 11 of 364 (3.0%) with late DOAC initiation among those with minor stroke (odds ratio [OR], 0.89; 95% CI, 0.38-2.10); in 11 of 388 (2.8%) with early DOAC initiation vs 14 of 392 (3.6%) with late DOAC initiation among those with moderate stroke (OR, 0.80; 95% CI, 0.35-1.74); and in 8 of 219 (3.7%) with early DOAC initiation vs 16 of 228 (7.0%) with late DOAC initiation among those with major stroke (OR, 0.52; 95% CI, 0.21-1.18). The 95% CI for the estimated risk difference of the primary outcome in early anticoagulation was −2.78% to 2.12% for minor stroke, −3.23% to 1.76% for moderate stroke, and −7.49% to 0.81% for major stroke. There was no significant treatment interaction for the primary outcome. For infarct size, interrater reliability was moderate (κ = 0.675; 95% CI, 0.647-0.702) for local vs core laboratory raters and strong (κ = 0.875; 95% CI, 0.855-0.894) between core laboratory raters.

Conclusions and Relevance   The treatment effect of early DOAC initiation did not differ in people with minor, moderate, or major stroke assessed by brain imaging. Early treatment was not associated with a higher rate of adverse events, especially symptomatic intracranial hemorrhage, for any infarct size, including major stroke.

Trial Registration   ClinicalTrials.gov Identifier: NCT03148457

Read More About

Goeldlin MB , Hakim A , Branca M, et al. Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation : Post Hoc Analysis of the ELAN Randomized Clinical Trial . JAMA Neurol. Published online May 28, 2024. doi:10.1001/jamaneurol.2024.1450

Manage citations:

© 2024

Artificial Intelligence Resource Center

Neurology in JAMA : Read the Latest

Browse and subscribe to JAMA Network podcasts!

Others Also Liked

Select your interests.

Customize your JAMA Network experience by selecting one or more topics from the list below.

• Academic Medicine
• Acid Base, Electrolytes, Fluids
• Allergy and Clinical Immunology
• American Indian or Alaska Natives
• Anesthesiology
• Anticoagulation
• Art and Images in Psychiatry
• Artificial Intelligence
• Assisted Reproduction
• Bleeding and Transfusion
• Caring for the Critically Ill Patient
• Challenges in Clinical Electrocardiography
• Climate and Health
• Climate Change
• Clinical Challenge
• Clinical Decision Support
• Clinical Implications of Basic Neuroscience
• Clinical Pharmacy and Pharmacology
• Complementary and Alternative Medicine
• Consensus Statements
• Coronavirus (COVID-19)
• Critical Care Medicine
• Cultural Competency
• Dental Medicine
• Dermatology
• Diabetes and Endocrinology
• Diagnostic Test Interpretation
• Drug Development
• Electronic Health Records
• Emergency Medicine
• End of Life, Hospice, Palliative Care
• Environmental Health
• Equity, Diversity, and Inclusion
• Facial Plastic Surgery
• Gastroenterology and Hepatology
• Genetics and Genomics
• Genomics and Precision Health
• Global Health
• Guide to Statistics and Methods
• Hair Disorders
• Health Care Delivery Models
• Health Care Economics, Insurance, Payment
• Health Care Quality
• Health Care Reform
• Health Care Safety
• Health Care Workforce
• Health Disparities
• Health Inequities
• Health Policy
• Health Systems Science
• History of Medicine
• Hypertension
• Images in Neurology
• Implementation Science
• Infectious Diseases
• Innovations in Health Care Delivery
• JAMA Infographic
• Law and Medicine
• Leading Change
• Less is More
• LGBTQIA Medicine
• Lifestyle Behaviors
• Medical Coding
• Medical Devices and Equipment
• Medical Education
• Medical Education and Training
• Medical Journals and Publishing
• Mobile Health and Telemedicine
• Narrative Medicine
• Neuroscience and Psychiatry
• Notable Notes
• Nutrition, Obesity, Exercise
• Obstetrics and Gynecology
• Occupational Health
• Ophthalmology
• Orthopedics
• Otolaryngology
• Pain Medicine
• Palliative Care
• Pathology and Laboratory Medicine
• Patient Care
• Patient Information
• Performance Improvement
• Performance Measures
• Perioperative Care and Consultation
• Pharmacoeconomics
• Pharmacoepidemiology
• Pharmacogenetics
• Pharmacy and Clinical Pharmacology
• Physical Medicine and Rehabilitation
• Physical Therapy
• Physician Leadership
• Population Health
• Primary Care
• Professional Well-being
• Professionalism
• Psychiatry and Behavioral Health
• Public Health
• Pulmonary Medicine
• Regulatory Agencies
• Reproductive Health
• Research, Methods, Statistics
• Resuscitation
• Rheumatology
• Risk Management
• Scientific Discovery and the Future of Medicine
• Shared Decision Making and Communication
• Sleep Medicine
• Sports Medicine
• Stem Cell Transplantation
• Substance Use and Addiction Medicine
• Surgical Innovation
• Surgical Pearls
• Teachable Moment
• Technology and Finance
• The Art of JAMA
• The Arts and Medicine
• The Rational Clinical Examination
• Tobacco and e-Cigarettes
• Translational Medicine
• Trauma and Injury
• Treatment Adherence
• Ultrasonography
• Users' Guide to the Medical Literature
• Vaccination
• Venous Thromboembolism
• Veterans Health
• Women's Health
• Workflow and Process
• Wound Care, Infection, Healing
• Register for email alerts with links to free full-text articles
• Access PDFs of free articles
• Manage your interests
• Save searches and receive search alerts

Degree studies

The undergraduate and graduate level degrees offered by the Faculty of Pharmacy are:

Bachelor of Science in Pharmacy (farmaseutti). The Bachelor’s degree consists of 180 credits and completing the degree takes three years.

Master of Science in Pharmacy (proviisori) .  The Master’s degree consists of 120 credits and completing the degree takes 5 years as a whole (Bachelor’s degree + two years). 

Master of Science in Master’s Programme in Pharmaceutical Research, Development and Safety . The master’s degree consists of 120 credits (ECTS), the equivalent to two years of full-time studying.

The Master’s Programme in Pharmaceutical Research, Development and Safety offers the opportunity to obtain a comprehensive overview of the life cycle of drugs and their use. The study program combines compulsory and optional courses with study tracks that focus on three possible subdisciplines: 1) drug discovery and pharmacology, 2) drug development and 3) medication safety and effectiveness. The programme combines research-oriented studies and high-quality pedagogical methods and integrates the perspective of Green and Sustainable Pharmacy into the curriculum, essential for managing the global sustainability challenge.

The language of tuition in the Bachelor of Science in Pharmacy (farmaseutti) degree and Master of Science in Pharmacy (proviisori)'s degree in Pharmacy is mainly Finnish. Therefore it is required that the applicants have a sufficient knowledge of Finnish or Swedish already when they apply. The language of the Master’s Programme in Pharmaceutical Research, Development and Safety is English.

When applying for these programmes, one must demonstrate the relevant language proficiency according to the University of Helsinki guidelines. 

Applicants can apply to:

• The undergraduate level programme only (right to take only Bachelor programme)
• The undergraduate and graduate level programmes (right to take both Bachelor and Master programmes)
• The Master’s programme in pharmaceutical research, development and safety (right to take the programme qualifying for a Master in Science degree)

The admission to the Bachelor of Science (Pharmacy) and Master of Science (Pharmacy) degrees is based on an entrance examination

The eligibility requirement for the Master of Science (Pharmacy) programme is a Bachelor of Science (Pharmacy) degree from a Finnish university. Applicants with another undergraduate degree from Finland or a Bachelor’s Degree (in Pharmacy or other subject) from abroad cannot apply to the Master of Science (Pharmacy) Programme directly.